ciprofibrate has been researched along with Hyperlipoproteinemia Type I in 1 studies
Hyperlipoproteinemia Type I: An inherited condition due to a deficiency of either LIPOPROTEIN LIPASE or APOLIPOPROTEIN C-II (a lipase-activating protein). The lack of lipase activities results in inability to remove CHYLOMICRONS and TRIGLYCERIDES from the blood which has a creamy top layer after standing.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lima-Martínez, MM | 1 |
| Piñango, M | 1 |
| Lima-Ostos, M | 1 |
1 other study available for ciprofibrate and Hyperlipoproteinemia Type I
| Article | Year |
|---|---|
Primary hyperchylomicronemia syndrome treated with ciprofibrate in childhood.
Topics: Child, Preschool; Female; Fibric Acids; Humans; Hyperlipoproteinemia Type I; Hypolipidemic Agents | 2016 |